Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BTN3A1 | O00481 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1039509 | 0.81 | BTN3A1 (0.32) | BTN3A1 | |
| SCHEMBL320910 | 0.79 | P2RY2 (0.31) | BTN3A1 | |
| SCHEMBL6045772 | 0.71 | — | — | |
| SCHEMBL138687 | 0.71 | FBP1 (0.30) | — | |
| SCHEMBL9237063 | 0.70 | — | — | |
| SCHEMBL22394 | 0.70 | PYGB (0.33) | BTN3A1 | |
| SCHEMBL6045394 | 0.67 | NPSR1 (0.33) | — | |
| SCHEMBL6045671 | 0.65 | PYGB (0.32) | BTN3A1 | |
| SCHEMBL10380113 | 0.65 | — | — | |
| SCHEMBL25388821 | 0.64 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240216483-A1 | THERAPEUTIC REGIMEN WITH DNASE | PERI-NESS TECHNOLOGIES LTD (IL) | 2024-07-04 | — | — | US | disclosed |
| EP-4346879-A1 | THERAPEUTIC REGIMEN WITH DNASE | Peri-Ness Technologies Ltd (IL) | 2024-04-10 | — | — | EP | disclosed |
| WO-2022249170-A1 | THERAPEUTIC REGIMEN WITH DNASE | PERI-NESS TECHNOLOGIES LTD (IL) | 2022-12-01 | — | — | WO | disclosed |
| EP-3137099-B1 | DNASE FOR USE IN TREATING VASO-OCCLUSIVE CRISIS | INST NAT SANTE RECH MED (FR) | 2019-09-04 | — | — | EP | disclosed |
| EP-3137099-A1 | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR TREATING VASO-OCCLUSIVE CRISIS | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2017-03-08 | — | — | EP | disclosed |
| US-20170049862-A1 | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR TREATING VASO-OCCLUSIVE CRISIS | INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (FR) | 2017-02-23 | — | — | US | disclosed |
| EP-2965764-A1 | Methods and pharmaceutical compositions for treating vaso-occlusive crisis | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2016-01-13 | — | — | EP | disclosed |
| WO-2015165944-A1 | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR TREATING VASO-OCCLUSIVE CRISIS | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2015-11-05 | — | — | WO | disclosed |
| US-9149513-B2 | Method and pharmacological composition for the diagnosis and treatment of male sub-fertility | PERINESS LTD. (IL) | 2015-10-06 | — | — | US | disclosed |
| US-20130121985-A1 | METHOD AND PHARMACOLOGICAL COMPOSITION FOR THE DIAGNOSIS AND TREATMENT OF MALE SUB-FERTILITY | BARTOOV BENJAMIN (IL) | 2013-05-16 | — | — | US | disclosed |
| EP-2416155-A1 | Selecting sperm cells in a sperm cell population for use in an assited reproduction technique | Periness Ltd. (IL) | 2012-02-08 | — | — | EP | disclosed |
| EP-2416156-A1 | Method for determining a male fertility status | Periness Ltd. (IL) | 2012-02-08 | — | — | EP | disclosed |
| US-20110033438-A1 | Method and pharmacological composition for the diagnosis and treatment of male | PERINESS LTD. (IL) | 2011-02-10 | — | — | US | disclosed |
| EP-2086642-A2 | METHOD AND PHARMACOLOGICAL COMPOSITION FOR THE DIAGNOSIS AND TREATMENT OF MALE SUB-FERTILITY | Periness Ltd. (IL) | 2009-08-12 | — | — | EP | disclosed |
| WO-2008047364-A2 | METHOD AND PHARMACOLOGICAL COMPOSITION FOR THE DIAGNOSIS AND TREATMENT OF MALE SUB-FERTILITY | PERINESS LTD. (IL) | 2008-04-24 | — | — | WO | disclosed |